Skip to content
Search

Latest Stories

UKRI Chief Executive To Visit India To address Newly Formed PM-STIAC

Chief Executive of UK Research and Innovation (UKRI), Professor Sir Mark Walport, is on a two-day visit to India’s capital city, Delhi this week to strengthen ongoing research relationships and address the newly-formed prime minister’s science, technology and innovation advisory council (PM-STIAC).

Mark Walport and Dr Tim Wheeler, Director International UK Research and Innovation, will also visit three Newton-Bhabha projects, which highlight the UK and India’s research collaborations.


The three projects, advance the efficiency and production potential of solar cells, develop and test innovative approaches to optimise agricultural nitrogen management to help meeting food security goals, and study the early life health effects of exposure to air pollution.

Mark Walport said, “in a world that depends on science and innovation to help address shared challenges, the creation of the prime minister’s science, technology and innovation advisory council comes at an exciting time for both India and its international partners. The UKRI-India collaboration has come a long way to provide solutions through its high-quality joint programmes and to prepare for future challenges.”

Professor K VijayRaghavan, principal scientific adviser to the Indian government said, “the ultimate goal of building a prosperous society and economy can be achieved through effective quality research, innovation and policies. As most of the challenges faced today are global in nature, it is important that India effectively leverages international science and technology collaboration to address these issues...”

The PM-STIAC is a new overarching body that assesses specific science and technology domains in India and formulates interventions and road-maps. It advises India’s prime minister on all matters of science, technology and innovation and monitors the implementation of the prime minister’s vision for the nation.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
India-US trade talks collapse over tariff disputes

FILE PHOTO: US president Donald Trump and Indian prime minister Narendra Modi shake hands as they attend a joint press conference at the White House in Washington, D.C., U.S., February 13, 2025. REUTERS/Kevin Lamarque.

India-US trade talks collapse over tariff disputes

TRADE talks between India and the US have hit a roadblock over disagreements on import duties for auto components, steel and farm goods, Indian officials with direct knowledge said, dashing hopes of reaching a deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

The deadlock marks a sharp shift from earlier optimism, following Trump's claim that New Delhi had proposed a "no tariffs" agreement for American goods, and officials from both sides suggesting India could be among the first countries to strike a deal on the new US tariffs.

Keep ReadingShow less